SV HEALTH INVESTORS
SV Health Investors, formerly SV Life Sciences, is a leading healthcare and life sciences venture capital and growth equity firm. Their goal is to transform healthcare – one investment at a time – by supporting the entrepreneurs who create and build breakthrough companies and treatments. With over $2 billion in capital under management in seven private healthcare funds, a 20-year track record in the US and Europe and offices in Boston, San Francisco and London, SV Health Investors drives game-changing innovation.
SV HEALTH INVESTORS
Industry:
Biotechnology Health Care Life Science Medical Device Venture Capital
Founded:
1993-01-01
Status:
Active
Contact:
+1 617 367 8100
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Tag Manager Google Analytics Google Maps LetsEncrypt SSL By Default Global Site Tag
Similar Organizations
BAROnova
BAROnova is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Echo Therapeutics
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Longitude Capital
Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.
RA Capital Management
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Telcare
Telcare develops machine-2-machine cellular technology that wirelessly connects patients and physicians to cure chronic illnesses.
The Column Group
The Column Group is a venture capital firm dedicated to developing biotechnology companies.
Current Advisors List
Advisor
2023-11-01
Current Employees Featured
Eugene Hill Managing Partner @ SV Health Investors
Managing Partner
1999-01-01
Kate Bingham Managing Partner @ SV Health Investors
Managing Partner
1991-09-01
Michael Balmuth Managing Partner @ SV Health Investors
Managing Partner
2014-07-01
Greg Madden Managing Partner @ SV Health Investors
Managing Partner
2020-12-01
Paul LaViolette Managing Partner, Chief Operating Officer @ SV Health Investors
Managing Partner, Chief Operating Officer
Michael Ross Senior Partner @ SV Health Investors
Senior Partner
2001-01-01
Tom Flynn Managing Partner @ SV Health Investors
Managing Partner
2011-01-01
Bruce A. Peacock Venture Partner @ SV Health Investors
Venture Partner
2006-01-01
Nikola Trbovic Partner @ SV Health Investors
Partner
2022-01-01
Jamil M. Beg Partner @ SV Health Investors
Partner
2024-01-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2023-06-20 | Robling Medical | Robling Medical acquired by SV Health Investors | N/A |
| 2021-02-11 | HPS / PayMedix | HPS / PayMedix acquired by SV Health Investors | N/A |
| 2014-11-05 | Ximedica | Ximedica acquired by SV Health Investors | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-05-14 | Brixton Biosciences | SV Health Investors investment in Series B - Brixton Biosciences | 33 M USD |
| 2024-04-02 | Miach Orthopaedics | SV Health Investors investment in Series B - Miach Orthopaedics | 20 M USD |
| 2024-02-13 | BioAge Labs | SV Health Investors investment in Series D - BioAge Labs | 170 M USD |
| 2023-11-28 | Harness Therapeutics | SV Health Investors investment in Seed Round - Harness Therapeutics | 4 M GBP |
| 2023-11-14 | Eyebiotech | SV Health Investors investment in Series A - Eyebiotech | 65 M USD |
| 2023-09-27 | Sitryx Therapeutics | SV Health Investors investment in Series A - Sitryx Therapeutics | 39 M USD |
| 2023-09-06 | Nimbus Therapeutics | SV Health Investors investment in Private Equity Round - Nimbus Therapeutics | 210 M USD |
| 2023-04-27 | Therini Bio | SV Health Investors investment in Series A - Therini Bio | 36 M USD |
| 2023-01-25 | HPS / PayMedix | SV Health Investors investment in Private Equity Round - HPS / PayMedix | 25 M USD |
| 2022-12-06 | Pulmocide | SV Health Investors investment in Series C - Pulmocide | 52 M USD |
More informations about "SV Health Investors"
SV Health Investors - Crunchbase Investor Profile
SV Health Investors, formerly SV Life Sciences, is a leading healthcare and life sciences venture capital and growth equity firm. Their goal is to transform healthcare – one investment at a time – by supporting the entrepreneurs who …See details»
SV Health Investors - LinkedIn
SV Health Investors is a specialist healthcare fund manager, investing across stages, geographic regions, and sectors, with expertise spanning biotechnology, dementia, healthcare growth ...See details»
SV Health Investors - The Org
SV Health Investors, formerly SV Life Sciences, is a leading healthcare and life sciences venture capital and growth equity firm.Their goal is to transform healthcare – one investment at a time …See details»
SV Health Investors - Investments, Portfolio & Company Exits
Jun 20, 2023 SV Health Investors 's most notable exits include BioAge Labs, Amwell, and Xilio Therapeutics. SV Health Investors has acquired 3 organizations. Their most recent acquisition …See details»
Stephen Kahane - SV Health Investors
In the UK, SV Health Managers (registered in England OC 308829, VAT 227 0451 34) is authorised and regulated by the Financial Conduct Authority ('FCA'). It is entered into the …See details»
SV Health Investors - Funding, Financials, Valuation & Investors
9 rows SV Health Investors has raised 8 funds, their latest being SV Biotech Crossover Opportunities Fund. This fund was announced on Dec 31, 2022 and raised a total of . …See details»
British Patient Capital announces £25m commitment to SV Health ...
3 days ago London, 20 March 2025: British Patient Capital, a commercial subsidiary of the British Business Bank, has made a £25 million commitment to the Dementia Discovery Fund 2 …See details»
Capital AUM | SV Health Investors Overview
SV Health Investors has a proven track record of successful investments in a wide array of healthcare sectors, including biopharmaceuticals, medical devices, diagnostics, and digital …See details»
Investment firm secures $250M to fund dementia drug development
2 days ago British investment firm SV Health Investors has secured $250 million to go toward the development of first-in-class therapeutics for dementia, the second such fund the venture …See details»
Fundopedia | Sv Health Investors
Historically, SV has managed diversified, multi-sector and multi-strategy healthcare private equity and venture capital funds. As a response to increasingly specialized needs of Limited Partners …See details»
Nikki Hecht - SV Health Investors
Nikki joined SV Health Investors in February 2024 as an Executive Assistant to the Biotech Team. ... Human Resources, and Operations roles at State Services Organization, West, Lane and …See details»
SV Health Investors | LinkedIn
SV Health Investors | 11,161 followers on LinkedIn. Investing in tomorrow's healthcare breakthroughs | SV Health Investors is a specialist healthcare fund manager, investing across …See details»
SV Health Investors announces acquisition of Nordic Consulting …
Jun 8, 2022 SV Health Investors is a growth equity and venture capital firm dedicated to investments in the healthcare and life sciences sector. Founded in 1993 with offices in Boston …See details»
SV Health Investors announces acquisition of Nordic Consulting …
BOSTON, June 8, 2022 /PRNewswire/ -- SV Health Investors ("SV") is pleased to announce the acquisition of Nordic Consulting Partners ("Nordic") by Accrete Health Partners ("Accrete"), a …See details»
SV Health Investors nabs $250M to fund dementia-focused biotechs
2 days ago SV Health InÂvestors has added $250 milÂlion to its hunt for new therÂaÂpeuÂtics for deÂmenÂtia, Alzheimer’s and othÂer neuÂrodeÂgenÂerÂaÂtive disÂeases. The LonÂdon-based life ...See details»
AeroCare Announces Completion of Acquisition by AdaptHealth
Feb 2, 2021 SV Health Investors is a leading healthcare fund manager committed to investing in tomorrow's healthcare breakthroughs. The SV family of funds invests across stages, …See details»
SV Health Investors Promotes Greg Madden to Managing Partner
BOSTON and LONDON, Dec. 15, 2020 (GLOBE NEWSWIRE) -- SV Health Investors, a leading transatlantic venture capital and growth equity firm, is pleased to announce that it has …See details»
SV HEALTH INVESTORS, LLC - HIPAASpace
SV HEALTH INVESTORS, LLC BUSINESS ADDRESS EIN 861154144 An Employer Identification Number (EIN) is also known as a Federal Tax Identification Number, and is used …See details»
HPS/PayMedix Closes on $25 Million in New Funding - SV Health …
Credit funds managed by SVB Capital lead new funding round to finance growth of PayMedix Healthcare Payment Solution. MILWAUKEE, Jan. 25, 2023 /PRNewswire/ -- Health Payment …See details»
Prilenia Achieves Last Patient Last Visit in Phase 3 PROOF-HD …
Mar 28, 2023 Founded in 1993 in Rochester, NY, the Huntington Study Group (HSG) is a not-for-profit organization composed of the world’s first and largest collaborative network of over …See details»